Fighting cancer with rejection-resistant, ‘off-the-shelf’ therapeutic T cells

This post was originally published on this site

Personalized cancer treatments are no longer just options of the future. In the past few years, researchers have made significant progress in ‘teaching’ the body’s immune T cells to recognize and kill specific cancer cells, and human clinical trials have shown …

Click here to read full article